Physician profile
James K Grant
NPI 1275973125
$2,490.95
in general payments reported to CMS, 2019-2025
14 companies · $485 in 2025
The $485 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.57 · 2020: $31.14 · 2021: $1,738 · 2022: $70.05 · 2023: $51.77 · 2024: $67.97 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,631.64 | 2019-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $159.21 | 2021-2025 | |
| Tarsus Pharmaceuticals, INC. | $117.62 | 2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $111.74 | 2025 | Acthar |
| Alcon Vision LLC | $103.54 | 2019-2025 | Total30, Precision7 |
| Ivantis, INC | $102.85 | 2021 | |
| Allergan, INC. | $85.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $69.58 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $31.21 | 2025 | Humphrey Hfa |
| Oyster Point Pharma, INC. | $19.93 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Coopervision INC. | $14.64 | 2024 | Clariti Contact Lens |
| Kala Pharmaceuticals, INC. | $12.61 | 2021 | |
| Shire North American Group INC | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Grant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.